Merck Sharp & Dohme Corp. et al v. Actavis Laboratories FL, Inc. et al
| MSD Investment Holdings (Ireland), Optimer Pharmaceuticals LLC, Merck Sharp & Dohme Corp., MSD International GmbH and Cubist Pharmaceuticals LLC |
| Teva Pharmaceuticals USA, Inc., Actavis Laboratories FL, Inc. and Actavis Pharma, Inc. |
| 0:2020cv60110 |
| January 17, 2020 |
| US District Court for the Southern District of Florida |
| Patent - Abbreviated New Drug Application(ANDA) |
| 15 U.S.C. ยง 1126 |
| None |
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Florida Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
